SCHEMBL937100

SCHEMBL937100

O=C(O)COCC1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2374514 0.91 PTGIR (0.50)
Formic Acid SCHEMBL28279122 0.91 PTGIR (0.50)
SCHEMBL2374517 0.91 PTGIR (0.50)
SCHEMBL6345787 0.91 PTGIR (0.49)
SCHEMBL23851385 0.89 PLG (0.50)
SCHEMBL1118701 0.89 PLG (0.50)
SCHEMBL16888038 0.89 PTGIR (0.49)
SCHEMBL6517561 0.89 PLG (0.50)
SCHEMBL9132825 0.89 LMNA (0.53)
SCHEMBL2346158 0.89 LMNA (0.53)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 53 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018109781-A1 A PROCESS FOR THE PREPARATION OF FIROCOXIB SEQUENT SCIENTIFIC LIMITED (IN) 2018-06-21 WO claimed
EP-1218366-B1 METHOD FOR PRODUCING COX-2 INHIBITORS MERIAL SAS (FR) 2005-09-14 EP claimed
US-6541646-B2 Reacting an oxirane compound containing phenylsulfonyl group with an acid in an anhydrous medium to form an intermediate, reacting the intermediate with a storng base in an aprotic solvent to form an ester compound,dehydrating the ester comp. MERIAL (FR) 2003-04-01 US claimed
US-20030028036-A1 Method of preparing COX-2 inhibitors MERIAL (FR) 2003-02-06 US claimed
US-20260083708-A1 IL-17 MODULATORS AND USES THEREOF NNOCARE PHARMA INC (US) 2026-03-26 US disclosed
CN-114671864-B Heteroaryl substituted pyridines and methods of use 艾伯维公司 2025-04-08 CN disclosed
US-20230257352-A1 RAF KINASE INHIBITORS AND METHODS OF USE THEREOF DECIPHERA PHARMACEUTICALS, LLC 2023-08-17 US disclosed
US-20230257352-A1 RAF KINASE INHIBITORS AND METHODS OF USE THEREOF DECIPHERA PHARMACEUTICALS, LLC 2023-08-17 US disclosed
US-20220340893-A1 BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES NUEVOLUTION A/S (DK) 2022-10-27 US disclosed
CN-114671864-A Heteroaryl substituted pyridines and methods of use 艾伯维公司 2022-06-28 CN disclosed
CN-110105314-B Method for preparing feloxicib 江苏君若药业有限公司 2022-05-17 CN disclosed
CN-109311864-B Heteroaryl substituted pyridines and methods of use 艾伯维公司 2022-05-10 CN disclosed
EP-1218366-B8 METHOD FOR PRODUCING COX-2 INHIBITORS MERIAL SAS (FR) 2005-11-09 EP disclosed
EP-1218366-B1 METHOD FOR PRODUCING COX-2 INHIBITORS MERIAL SAS (FR) 2005-09-14 EP disclosed
US-20050065143-A1 Pyridazine derivatives and their use as therapeutic agents XENON PHARMACEUTICALS INC. (CA) 2005-03-24 US disclosed
WO-2005011655-A2 PYRIDAZINE DERIVATIVES AND THEIR USE AS THERAPEUTIC AGENTS XENON PHARMACEUTICALS INC. (CA) 2005-02-10 WO disclosed
US-6541646-B2 Reacting an oxirane compound containing phenylsulfonyl group with an acid in an anhydrous medium to form an intermediate, reacting the intermediate with a storng base in an aprotic solvent to form an ester compound,dehydrating the ester comp. MERIAL (FR) 2003-04-01 US disclosed
US-20030028036-A1 Method of preparing COX-2 inhibitors MERIAL (FR) 2003-02-06 US disclosed
EP-1218366-A2 METHOD FOR PRODUCING COX-2 INHIBITORS MERIAL (FR) 2002-07-03 EP disclosed
WO-2001027098-A2 METHOD FOR PRODUCING COX-2 INHIBITORS MERIAL (FR) 2001-04-19 WO disclosed